Biomarker Predicts Survival in Autoimmune Lung Disease
One major subgroup of patients with ILD arising from polymyositis/dermatomyositis (PM/DM) survived significantly longer when serum levels of interferon-λ3 were relatively low, researchers found.
https://t.co/2nYPBbNfCh https://t.co/n2Llxb7tdx
Links:
Biomarker Predicts Survival in Autoimmune Lung Disease | RheumNow
https://bit.ly/3U8hPzR
Jan-07-2024


